Fact CheckerSign in

NCT06718608Not yet recruiting

Natural Evolution of Muscle Structure and Stiffness Following Brain Lesion

Source: ClinicalTrials.gov · Last updated 5 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

We propose to carry out a single center, prospective, interventional trial to assess the natural evolution of lower limb muscle structure and muscle stiffness of hemiparetic patients following brain damage. Patients will be assessed two weeks, one month, three months and six months after their brain lesion. Secondary objectives: To compare the muscle stiffness and structure of patients who will develop muscle overactivity to patients who won't develop muscle overactivity. To compare the muscle structure and muscle stiffness of the spastic lower limb muscles and the non-spastic lower limb muscles in the affected limb. To compare the muscle structure and muscle stiffness of the affected and the non-affected lower limb. To study the relationship between impairment and function by applying a comprehensive and original method to assess all aspects from muscle structure and mechanics to patient's functional capacities.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
2 Dec 2024
Start date
2 Dec 2024
Primary completion date
31 Dec 2025
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Diseases
Stroke
NCT number
NCT06718608

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 2 Dec 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Underlying neuromuscular disease (e.g. myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis)

Other

  • Bilateral limb paresis
  • Major cognitive impairments limiting the functional evaluation
  • Neurological or orthopedic affection interfering with the paretic limbs function
  • Contraindication to perform MRI Subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.

Who the study is looking for

  • Female or male ≥ 18 years and ≤ 80 years at screening
  • Hemiparesis secondary to a first stroke or traumatic brain injury
  • \< 1 month post-stroke/brain injury Subjects must meet all of the inclusion criteria in order to be eligible to participate in the study.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cliniques universitaires Saint-Luc
Coordinator of this site? Confirm its status
BrusselsBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.